V Devauchelle

Summary

Country: France

Publications

  1. ncbi [What place for DNA microarray in inflammatory diseases?]
    V Devauchelle
    Unité Inserm 567, Institut Cochin, Pavillon Hardy A, 1 étage, 27 rue du Faubourg Saint Jacques, 75674 Paris, France
    Rev Med Interne 25:732-9. 2004
  2. ncbi DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets
    V Devauchelle
    Institut Cochin, Paris, France
    Genes Immun 5:597-608. 2004
  3. ncbi BAFF and rheumatic autoimmune disorders: implications for disease management and therapy
    S Bosello
    Laboratory of Immunology, Medical School, Brest, France
    Int J Immunopathol Pharmacol 20:1-8. 2007
  4. ncbi Is hypocomplementemia useful for diagnosing or predicting extra-articular manifestations in patients with rheumatoid arthritis?
    A Saraux
    Rheumatology Department, CHU de Brest, France
    Joint Bone Spine 68:487-92. 2001
  5. ncbi B cell-ablative therapy: where are we now?
    A Bordron
    Int J Immunopathol Pharmacol 20:655-9. 2007

Collaborators

Detail Information

Publications5

  1. ncbi [What place for DNA microarray in inflammatory diseases?]
    V Devauchelle
    Unité Inserm 567, Institut Cochin, Pavillon Hardy A, 1 étage, 27 rue du Faubourg Saint Jacques, 75674 Paris, France
    Rev Med Interne 25:732-9. 2004
    ..In few years it has become an obligatory step in massive gene expression study. The enormous quantity of results generated and the new way of thinking allowed make this kind of study a true revolution...
  2. ncbi DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets
    V Devauchelle
    Institut Cochin, Paris, France
    Genes Immun 5:597-608. 2004
    ..It is proposed that such an approach allows valuable diagnosis/prognostics tools in RA to be established and potential targets for combating the disease to be identified...
  3. ncbi BAFF and rheumatic autoimmune disorders: implications for disease management and therapy
    S Bosello
    Laboratory of Immunology, Medical School, Brest, France
    Int J Immunopathol Pharmacol 20:1-8. 2007
    ..Recent works suggest that antagonizing the protein (or competing for its receptors) is relevant to the treatment. Advances in our understanding of the BAFF system offers the opportunity to improve our therapeutic approach...
  4. ncbi Is hypocomplementemia useful for diagnosing or predicting extra-articular manifestations in patients with rheumatoid arthritis?
    A Saraux
    Rheumatology Department, CHU de Brest, France
    Joint Bone Spine 68:487-92. 2001
    ..The objective of this study was to evaluate whether complement assays are useful in diagnosing or predicting SEAMs of RA...
  5. ncbi B cell-ablative therapy: where are we now?
    A Bordron
    Int J Immunopathol Pharmacol 20:655-9. 2007
    ..The efficacy in different diseases, and the emergence of new anti-CD20 Abs raise many questions. Thus, their detailed understanding can lead to a better issue for inhibition of immune responses...